0001762996-20-000003.txt : 20200413
0001762996-20-000003.hdr.sgml : 20200413
20200413164517
ACCESSION NUMBER: 0001762996-20-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200413
DATE AS OF CHANGE: 20200413
EFFECTIVENESS DATE: 20200413
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Optofluidics, Inc.
CENTRAL INDEX KEY: 0001762996
IRS NUMBER: 273016935
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-364845
FILM NUMBER: 20789137
BUSINESS ADDRESS:
STREET 1: 1828 EL CAMINO REAL
STREET 2: SUITE 703
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 215-253-5777
MAIL ADDRESS:
STREET 1: 1828 EL CAMINO REAL
STREET 2: SUITE 703
CITY: BURLINGAME
STATE: CA
ZIP: 94010
D
1
primary_doc.xml
X0708
D
LIVE
0001762996
Optofluidics, Inc.
1828 EL CAMINO REAL
SUITE 703
BURLINGAME
CA
CALIFORNIA
94010
215-253-5777
DELAWARE
None
None
Corporation
true
Robert
Wicke
1828 El Camino Real
Suite 703
Burlingame
CA
CALIFORNIA
94010
Executive Officer
Director
CEO
Joseph
Keegan
1828 El Camino Real
Suite 703
Burlingame
CA
CALIFORNIA
94010
Director
Shahram
Hejazi
1828 El Camino Real
Suite 703
Burlingame
CA
CALIFORNIA
94010
Director
Chad
Souvignier
1828 El Camino Real
Suite 703
Burlingame
CA
CALIFORNIA
94010
Director
William
Snider
1828 El Camino Real
Suite 703
Burlingame
CA
CALIFORNIA
94010
Director
Casey
McGlynn
650 Page Mill Road
Palo Alto
CA
CALIFORNIA
94304
Executive Officer
Secretary
Biotechnology
Decline to Disclose
- 06b
false
2020-03-31
false
true
false
0
11592457
6738727
4853730
false
14
0
0
500000
$500,000 of the total proceeds shall be used for partial repayment of a Note held by Broadoak Fund III, LLC, the manager of which is William Snider. Mr. Snider is a Director of the company.
false
Optofluidics, Inc.
Robert Wicke
Robert Wicke
CEO
2020-04-13